BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23995569)

  • 1. Clinical significance of blood coagulation factor XIII activity in adult Henoch-Schönlein purpura.
    Matayoshi T; Omi T; Sakai N; Kawana S
    J Nippon Med Sch; 2013; 80(4):268-78. PubMed ID: 23995569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Japanese Pediatric Group.
    Fukui H; Kamitsuji H; Nagao T; Yamada K; Akatsuka J; Inagaki M; Shike S; Kobayashi Y; Yoshioka K; Maki S
    Thromb Res; 1989 Dec; 56(6):667-75. PubMed ID: 2699100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura.
    Sano H; Izumida M; Shimizu H; Ogawa Y
    Eur J Pediatr; 2002 Apr; 161(4):196-201. PubMed ID: 12014385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors.
    Kaku Y; Nohara K; Honda S
    Kidney Int; 1998 Jun; 53(6):1755-9. PubMed ID: 9607209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)].
    Dalens B; Bezou MJ; Goumy P; Déméocq F; Menut G
    Arch Fr Pediatr; 1980 Feb; 37(2):99-101. PubMed ID: 7396652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Henoch-Schönlein purpura with severe abdominal pain treated with dapsone and factor XIII concentrate.
    Shimomura N; Kawai K; Watanabe S; Katsuumi K; Ito M
    J Dermatol; 2005 Feb; 32(2):124-7. PubMed ID: 15906543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of plasma factor XIII in Henoch-Schönlein purpura.
    Kaneko K; Fujii S; Shono T; Matsumoto Y; Arii N; Kaneko K
    Pediatr Nephrol; 2004 Jun; 19(6):702-3. PubMed ID: 15054647
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences between adult and pediatric onset Henoch-Schonlein purpura from North India.
    Gupta V; Aggarwal A; Gupta R; Chandra Chowdhury A; Agarwal V; Lawrence A; Misra R
    Int J Rheum Dis; 2018 Jan; 21(1):292-298. PubMed ID: 29115055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of adult Henoch-Schönlein purpura with factor XIII concentrate.
    Utani A; Ohta M; Shinya A; Ohno S; Takakuwa H; Yamamoto T; Suzaki T; Danno K
    J Am Acad Dermatol; 1991 Mar; 24(3):438-42. PubMed ID: 2061441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Efficacy of factor XIII substitution.
    Kamitsuji H; Tani K; Yasui M; Taniguchi A; Taira K; Tsukada S; Iida Y; Kanki H; Fukui H
    Eur J Pediatr; 1987 Sep; 146(5):519-23. PubMed ID: 3678279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura.
    De Mattia D; Penza R; Giordano P; Del Vecchio GC; Aceto G; Altomare M; Schettini F
    Pediatr Nephrol; 1995 Oct; 9(5):603-5. PubMed ID: 8580019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased factor XIII activity during severe Henoch-Schoenlein purpura -- does it play a role?
    Prenzel F; Pfäffle R; Thiele F; Schuster V
    Klin Padiatr; 2006; 218(3):174-6. PubMed ID: 16688675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of coagulation parameters in the Schönlein-Henoch syndrome. Diagnostic value of factor XIII].
    Barberio G; Manganaro R; Ruggeri C; Cambria R; Gattarello A; Gemelli M
    Minerva Pediatr; 1981 Aug; 33(16):817-20. PubMed ID: 7311944
    [No Abstract]   [Full Text] [Related]  

  • 14. Henoch-Schönlein purpura with intracerebral hemorrhage.
    Imai T; Okada H; Nanba M; Kawada K; Kusaka T; Itoh S
    Brain Dev; 2002 Mar; 24(2):115-7. PubMed ID: 11891106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatoid purpura and intravenous immunoglobulins].
    Ruellan A; Khatibi M; Staub T; Martin T; Storck D; Christmann D
    Rev Med Interne; 1997; 18(9):727-9. PubMed ID: 9365726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical tumour-like involvement of the colon in Henoch-Schonlein purpura successfully treated with the administration of factor XIII.
    Ando K; Fujiya M; Sugiyama R; Nata T; Nomura Y; Ueno N; Kashima S; Ishikawa C; Inaba Y; Ito T; Moriichi K; Okamoto K; Ikuta K; Watari J; Mizukami Y; Kohgo Y
    BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
    Li MM; Liu N; Zhagn M; Xue HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Henoch-Schönlein purpura in a child with Guillain-Barré syndrome.
    Fuchigami T; Hasegawa M; Hashimoto K; Fujita Y; Inamo Y
    Pediatr Neurol; 2010 Dec; 43(6):431-4. PubMed ID: 21093736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of fibrin stabilising factor in Schönlein-Henoch syndrome.
    Dalens B; Travade P; Labbé A; Bezou MJ
    Arch Dis Child; 1983 Jan; 58(1):12-4. PubMed ID: 6830268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe gastrointestinal vasculitis in Henoch-Schoenlein purpura: pathophysiologic mechanisms, the diagnostic value of factor XIII, and therapeutic options.
    Shin JI; Lee JS
    Eur J Pediatr; 2007 Nov; 166(11):1199-200; author reply 1201. PubMed ID: 17333275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.